Cardiovascular InflammationCardiovascular Inflammation
Prevalencia: hs-CRP >2 mg/L present in ~25% of US adults
Evidence-Ranked Ingredients
About
Chronic low-grade systemic inflammation measured by hs-CRP, now recognized as an independent cardiovascular risk factor. The CANTOS trial validated the inflammatory hypothesis of atherosclerosis by showing reducing inflammation (IL-1beta) without affecting lipids reduced cardiovascular events.
Common Symptoms
Risk Factors
- Obesity (visceral adiposity)
- Metabolic syndrome
- Periodontal disease
- Autoimmune conditions
- Smoking
- Sedentary lifestyle
- Poor diet
Frequently Asked Questions
What supplements may help with Cardiovascular Inflammation?
How is the evidence for Cardiovascular Inflammation supplements graded?
How many studies on Cardiovascular Inflammation supplements have been reviewed?
What are common symptoms of Cardiovascular Inflammation?
Related Conditions
Afecciones que comparten ingredientes estudiados
Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.